MASI (MASI)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 8.8.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency for MASI demonstrates a robust spread between return on invested capital and the weighted average cost of capital, yielding +6.2%, which suggests strong value creation potential despite operational headwinds. This high ROIC is underpinned by exceptional gross margins at 61.9% and disciplined leverage, yet it coexists with negative net margins of -9.9%, indicating that operating expenses are significantly eroding top-line profitability. Financial integrity appears solid based on a Piotroski F-Score of 6/9 and an Altman Z-Score of 8.8, while the Beneish M-Score of -3.66 points to low earnings manipulation risk; however, revenue growth moderating at 9.4% year-over-year reveals that high capital efficiency has not yet translated into scalable bottom-line performance.
Valuation metrics present a notable divergence between market pricing and intrinsic value models, with the current P/E ratio of 46.3x substantially exceeding historical norms and likely trading above sector averages given the negative net income context. While revenue expansion is positive, the market appears to be pricing in aggressive future margin normalization or acceleration that has not yet materialized. A discounted cash flow analysis anchors fair value at $65, implying that current share prices may reflect optimistic growth assumptions rather than realized fundamentals, particularly as the company navigates the transition from high gross profitability to sustainable net earnings.
The risk-reward profile is characterized by a tension between strong balance sheet health and deteriorating or absent bottom-line returns. Although the Altman Z-Score suggests low bankruptcy risk and the Beneish M-Score indicates clean earnings reporting, the persistent negative net margin creates uncertainty regarding long-term cash flow generation relative to the elevated valuation multiple. Investors must weigh whether the 9.4% revenue growth can eventually compress operating expenses enough to align with the impressive ROIC-WACC spread before the current premium valuation becomes unsustainable.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 10% | 12% | 14% |
|---|---|---|---|
| 2% | $77 | $59 | $47 |
| 3% | $86 | $65 | $51 |
| 4% | $99 | $72 | $55 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=12.0%, terminal growth 3%. Fair value $65 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
MASI Capital Efficiency
How efficiently does MASI convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
MASI converts 56% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 6.2% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-06-11 | 19 | $179.95 | $3,419.05 |
| 2026-06-10 | 587 | $179.95 | $105,630.65 |
| 2026-06-05 | 86,455 | $178.90 | $15.5M |
| 2026-06-02 | 51 | $178.59 | $9,108.09 |
| 2026-06-01 | 788 | $178.45 | $140,618.6 |
| 2026-05-27 | 26 | $178.67 | $4,645.42 |
| 2026-05-20 | 9,686 | $178.80 | $1.7M |
| 2026-05-18 | 6 | $178.47 | $1,070.82 |
| 2026-05-06 | 1,088 | $178.58 | $194,295.04 |
| 2026-05-05 | 3,517 | $178.21 | $626,764.57 |
| 2026-04-29 | 620 | $178.51 | $110,676.2 |
| 2026-04-24 | 223 | $178.71 | $39,852.33 |
| 2026-04-16 | 68 | $178.39 | $12,130.52 |
| 2026-04-14 | 745 | $178.47 | $132,960.15 |
| 2026-04-10 | 874 | $178.33 | $155,860.42 |
| 2026-04-06 | 589 | $178.59 | $105,189.51 |
| 2026-03-26 | 161 | $178.09 | $28,672.49 |
| 2026-03-23 | 9,300 | $178.24 | $1.7M |
| 2026-03-06 | 790 | $175.46 | $138,613.4 |
| 2026-03-04 | 5,560 | $175.36 | $975,001.6 |
| 2026-03-02 | 8,000 | $175.35 | $1.4M |
| 2026-02-23 | 124 | $175.10 | $21,712.4 |
| 2026-02-12 | 911 | $135.04 | $123,021.44 |
| 2026-02-11 | 360 | $134.10 | $48,276 |
| 2026-02-10 | 400 | $134.80 | $53,920 |
| 2026-02-04 | 7,906 | $139.13 | $1.1M |
| 2026-02-02 | 324 | $137.33 | $44,494.92 |
| 2026-01-22 | 22 | $146.21 | $3,216.62 |
| 2025-12-17 | 171 | $134.52 | $23,002.92 |
| 2025-12-16 | 92 | $137.40 | $12,640.8 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare MASI to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.